FDA Approves Tecentriq® as First Immunotherapy Regimen for Breast Cancer
A breakthrough therapy is offering unprecedented hope to women with metastatic triple negative breast.... Read More
It's a diagnosis everyone fears, but Tennessee Oncology and Sarah Cannon physician-scientist Erika P. Hamilton, MD said advances in clinical care and research are helping turn.... Read More